Is there an injection for multiple sclerosis (MS) patients to boost energy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No Specific Energy-Boosting Injection Exists for Multiple Sclerosis Patients

There is no FDA-approved injection specifically designed to boost energy in multiple sclerosis patients. Instead, management of fatigue in MS requires a multidisciplinary approach focused on identifying underlying causes and implementing appropriate interventions.

Understanding MS-Related Fatigue

Fatigue is one of the most common and disabling symptoms in MS, reported as the worst symptom by 50-60% of patients 1. It significantly impacts quality of life and daily functioning, often independent of physical disability level.

Recommended Approach to Managing MS-Related Fatigue

Step 1: Rule Out Contributing Factors

  • Assess for conditions that may worsen fatigue:
    • Urinary dysfunction
    • Pain
    • Muscle spasms
    • Sleep disorders
    • Malnutrition

Step 2: Nutritional Assessment and Support

  • Early detection and treatment of malnutrition by a multidisciplinary team is strongly recommended 2
  • Provide dietary advice and consider oral nutritional supplements for patients unable to meet nutritional needs through food intake 2
  • Malnutrition can compound existing MS symptoms including fatigue and muscle dysfunction 2

Step 3: Pharmacological Interventions

  • Amantadine is currently the only medication with sufficient evidence for treating MS-related fatigue 3
    • However, the clinical significance of its effect remains limited 4
    • Side effects are generally mild, with discontinuation rates <10% 4
  • Avoid stimulants for fatigue symptoms in patients with chronic multisymptom illness and symptoms consistent with myalgic encephalomyelitis/chronic fatigue syndrome 2

Step 4: Non-Pharmacological Approaches

Exercise Therapy

  • Exercise therapy has shown significant benefits for reducing fatigue in MS patients 5
  • Most effective types include:
    • Endurance training
    • Mixed training approaches
    • Other interventions like yoga 5
  • Exercise is generally safe and does not appear to increase risk of MS relapses 5

Rehabilitation

  • Structured rehabilitation program should include:
    • Pre-habilitation: Enhancing neuromuscular systems and respiratory function 2
    • Acute rehabilitation: Gentle mobilization with attention to platelet counts 2
    • Subacute rehabilitation: Optimizing physical fitness and independence 2
    • Community rehabilitation: Integration back to home life 2

Important Considerations

  • Fatigue management requires a multidisciplinary team including neurologists, MS nurses, occupational therapists, and physiotherapists 6
  • Assessment should use validated fatigue measures such as the Modified Fatigue Impact Scale (MFIS) or Fatigue Severity Scale (FSS) 3
  • Current evidence for most pharmacological interventions remains limited, highlighting the need for more rigorous research 1

Pitfalls to Avoid

  • Don't assume fatigue is simply part of MS and cannot be improved
  • Don't rely solely on pharmacological approaches
  • Don't overlook the importance of treating underlying conditions that may contribute to fatigue
  • Don't initiate exercise programs without proper assessment and guidance
  • Don't expect immediate results; fatigue management typically requires a sustained, multifaceted approach

While patients may inquire about energy-boosting injections, it's important to focus on evidence-based approaches to fatigue management that address the underlying mechanisms and provide sustainable improvement in energy levels and quality of life.

References

Research

Management options in multiple sclerosis-associated fatigue.

Expert opinion on pharmacotherapy, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amantadine for fatigue in multiple sclerosis.

The Cochrane database of systematic reviews, 2003

Research

Exercise therapy for fatigue in multiple sclerosis.

The Cochrane database of systematic reviews, 2015

Research

Fatigue Management in Multiple Sclerosis.

Current treatment options in neurology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.